The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1158911520 11589115 20 F 2015 20160705 20151002 20160708 PER US-PFIZER INC-2015316316 PFIZER 66.00 YR M Y 88.00000 KG 20160708 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1158911520 11589115 1 PS SUTENT SUNITINIB MALATE 1 Oral 50 MG, DAILY, CYCLIC (28 DAYS ON/14 DAYS OFF) Y 21938 50 MG CAPSULE, HARD
1158911520 11589115 2 SS SUTENT SUNITINIB MALATE 1 Oral 50 MG, DAILY, CYCLIC (2 WEEKS ON/1 WEEK OFF) Y 21938 50 MG CAPSULE, HARD
1158911520 11589115 3 SS SUTENT SUNITINIB MALATE 1 Oral 37.5 MG, DAILY, CYCLIC (2 WEEKS ON/1 WEEK OFF) Y X731C 21938 37.5 MG CAPSULE, HARD
1158911520 11589115 4 SS SUTENT SUNITINIB MALATE 1 25 MG, CYCLIC (14 DAYS ON AND 7 DAYS OFF) (2 WEEKS ON/1 WEEK OFF) Y 21938 25 MG CAPSULE, HARD
1158911520 11589115 5 SS IMODIUM LOPERAMIDE HYDROCHLORIDE 1 Oral 2 MG, 1X/DAY, ONE TABLET ONCE A DAY 2 MG Y 0 2 MG TABLET QD
1158911520 11589115 6 SS IMODIUM LOPERAMIDE HYDROCHLORIDE 1 Oral 2 MG, 2X/DAY 2 MG Y 0 2 MG TABLET BID
1158911520 11589115 7 SS IMODIUM LOPERAMIDE HYDROCHLORIDE 1 Oral 2 MG, AS NEEDED (2,1,1,1 AND 1 ) 2 MG Y 0 2 MG TABLET
1158911520 11589115 8 SS IMODIUM LOPERAMIDE HYDROCHLORIDE 1 2 DF, 2X/DAY 2 MG Y 0 2 DF TABLET BID
1158911520 11589115 9 C MIRALAX POLYETHYLENE GLYCOL 3350 1 UNK 0
1158911520 11589115 10 C HYDROCORTISONE. HYDROCORTISONE 1 0
1158911520 11589115 11 C OMEPRAZOLE. OMEPRAZOLE 1 0
1158911520 11589115 12 C METAMUCIL PLANTAGO SEED 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1158911520 11589115 1 Metastatic renal cell carcinoma
1158911520 11589115 5 Diarrhoea
1158911520 11589115 9 Constipation

Outcome of event

Event ID CASEID OUTC COD
1158911520 11589115 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1158911520 11589115 Abdominal pain upper
1158911520 11589115 Acne
1158911520 11589115 Blister
1158911520 11589115 Bowel movement irregularity
1158911520 11589115 Burning sensation
1158911520 11589115 Chromaturia
1158911520 11589115 Diarrhoea
1158911520 11589115 Disease progression
1158911520 11589115 Dyspepsia
1158911520 11589115 Dyspnoea
1158911520 11589115 Fatigue
1158911520 11589115 Haematochezia
1158911520 11589115 Haemorrhoids
1158911520 11589115 Headache
1158911520 11589115 Metastatic renal cell carcinoma
1158911520 11589115 Muscle twitching
1158911520 11589115 Nausea
1158911520 11589115 Onychoclasis
1158911520 11589115 Pain in extremity
1158911520 11589115 Paraesthesia
1158911520 11589115 Proctalgia
1158911520 11589115 Pruritus
1158911520 11589115 Rash
1158911520 11589115 Terminal insomnia
1158911520 11589115 Tooth fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1158911520 11589115 1 20150908 0
1158911520 11589115 2 2015 0
1158911520 11589115 3 20151216 0
1158911520 11589115 4 20150908 0
1158911520 11589115 5 20151001 20151001 0
1158911520 11589115 6 201510 0
1158911520 11589115 8 201511 201512 0
1158911520 11589115 9 201505 201510 0